Details

Autor(en) / Beteiligte

• Fagnani, Sandra R.C.A.
• de Oliveira, Susana C.P.S.
• Monteiro, Juliana S.C.
• Sampaio, Fernando José Pires
• Crugeira, Pedro J.L.
• dos Santos, Jean N.
• Pinheiro, Antonio L.B.

Titel

Histological evaluation of skin lesions induced by Leishmania braziliensis treated by PACT using Laser light and 1.9 dimethyl-methylene blue

Ist Teil von

• Photodiagnosis and photodynamic therapy, 2022-06, Vol.38, p.102815-102815, Article 102815

Ort / Verlag

Netherlands: Elsevier B.V

Erscheinungsjahr

2022

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• •Leishmaniasis represents a global public health problem.•Histological evaluation in skin lesions caused by L. braziliensis after PACT was carried out.•1.9 Dimethyl methylene blue was used as a photosensitizer associated to Laser light.•PACT was able to reduce inflammation and increase tissue remodeling in leishmaniosis skin lesions. This study aimed to perform a histological evaluation in skin lesions caused by Leishmania braziliensis after PACT treatment using Laser associated with 1.9. dimethyl methylene blue BALB/c mouse ear infection model was used. A total of 40 animals were assigned into two groups considering time intervals at 5 and 10 weeks and subdivided into four subgroups: Control, Photosensitizer, Laser and PACT. Two therapeutic interventions were performed after the 5th week of infection at 48 h intervals. 1.9 Dimethyl methylene blue was used as a photosensitizer at the concentration of 7 ng/mL, with a non-invasive topical administration method associated with Laser (λ = 660 nm, 40 mW, 12 J/cm2). Sample collection occurred 5 or 10 weeks after therapeutic interventions. The main histological findings were observed in the laser and PACT groups at the 10-week evaluation. The Laser group showed reduced lymphoplasmacytic inflammation and histiocytes (p = 0.0079). The PACT group showed reductions in lymphoplasmacytic inflammation at 5 and 10 weeks, discrete reduction of histiocytes and a higher percentage of tissue remodeling. PACT with non-invasive topical administration of the photosensitizer was able to reduce lymphoplasmacytic inflammation and increase tissue remodeling in leishmaniosis skin lesions. This protocol may be easily used in humans and clinical trial shall be carried out to confirm the animal's findings.